1542 related articles for article (PubMed ID: 30638582)
1. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
2. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.
Bruni L; Diaz M; Barrionuevo-Rosas L; Herrero R; Bray F; Bosch FX; de Sanjosé S; Castellsagué X
Lancet Glob Health; 2016 Jul; 4(7):e453-63. PubMed ID: 27340003
[TBL] [Abstract][Full Text] [Related]
3. Management of cervical precancers: a global perspective.
Echelman D; Feldman S
Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
5. What school nurses need to know about cervical cancer, HPV, and the new vaccine.
Ehrhardt J
J Sch Nurs; 2007 Dec; 23(6):310-4. PubMed ID: 18052515
[TBL] [Abstract][Full Text] [Related]
6. Screening and prevention: cervical cancer.
Weinstein LC; Buchanan EM; Hillson C; Chambers CV
Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma viruses and cancer in the post-vaccine era.
Galani E; Christodoulou C
Clin Microbiol Infect; 2009 Nov; 15(11):977-81. PubMed ID: 19874381
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer.
Lea JS; Lin KY
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):233-53. PubMed ID: 22640713
[TBL] [Abstract][Full Text] [Related]
9. CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide.
Senkomago V; Duran D; Loharikar A; Hyde TB; Markowitz LE; Unger ER; Saraiya M
Emerg Infect Dis; 2017 Dec; 23(13):S101-7. PubMed ID: 29155666
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer: A global health crisis.
Small W; Bacon MA; Bajaj A; Chuang LT; Fisher BJ; Harkenrider MM; Jhingran A; Kitchener HC; Mileshkin LR; Viswanathan AN; Gaffney DK
Cancer; 2017 Jul; 123(13):2404-2412. PubMed ID: 28464289
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus vaccine for low and middle income countries: A step too soon?
Jindal HA; Kaur A; Murugan S
Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
17. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer and HPV vaccines in developing countries.
Karimi Zarchi M; Behtash N; Chiti Z; Kargar S
Asian Pac J Cancer Prev; 2009; 10(6):969-74. PubMed ID: 20192568
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
